🇺🇸 FDA
Patent

US 8841483

Compositions useful as inhibitors of voltage-gated sodium channels

granted A61PA61P1/04A61P13/02

Quick answer

US patent 8841483 (Compositions useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/04, A61P13/02, A61P19/02, A61P21/02